4 Jun 2015 15:22
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- Stock Screeners
- Share Chat
- FX
- News & RNS
- Events
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
ETX.L Share News (ETX)
ETX Share
Price
ETX Share
News
ETX Share
Chat
ETX Share
Trades
ETX
Live RNS
ETX Share
Charts
ETX Broker
Ratings
ETX Directors
Deals
ETX Financial
Diary
ETX
Fundamentals
ETX Short
Positions
ETX
Media
ETX.L Information
- There is currently no data for ETX
Watchlists are a member only feature
Login to your account
Don't have an account? Click here to register.e-Therapeutics shares jump following 40m equity issue
Mon, 11th Feb 2013 09:15
Drug discovery and development company e-Therapeutics is proposing to raise 40m pounds through an issue of new ordinary shares to existing and new institutional investors.The new shares will be priced at 32p, a premium of 4.0% to the closing mid-market price on Friday.Following the proposed issue, the company will have a pro-forma net cash and liquid resources of approximately £48m.According to the the company's update, the resources are intended to support its currently planned discovery and development activities to 2017, by which time, it said it believed that an out-licensing deal could be concluded for the company's lead cancer drug ETS2101.Professor Malcolm Young Chief Executive Officer of e-Therapeutics, said: "We appreciate the continuing support of existing investors and are also pleased to have attracted significant new investors to the company. With our financial position secure, we are well-placed to build further shareholder value based on our innovative platform and product portfolio."e-Therapeutics' share price was up 4.88% to 32.25p at 09:03 on Monday.MF
More News
4 Jul 2014 16:30
Daily Mail General Trust's Chairman sells £15.91m-worth of shares
Viscount Rothermere, the Chairman of Daily Mail and General Trust, has traded in £15.91m-worth of shares in the multi-media and information company. Selling the stock at 860p a piece, Rothermere benefited from the rise seen in the group's share price this week, which has seen it climbed 5.56%, or
Read more12 May 2014 11:49
e-Therapeutics Loss Widens As It Continues Pipeline Development
LONDON (Alliance News) - e-Therapeutics PLC Monday posted a widened pretax loss for 2013 as it continued to invest and develop its pipeline of products. The pharmaceutical company posted a pretax loss of GBP6.1 million, widened from GBP5.0 million, as it upped its research and development e
Read more8 May 2014 13:30
UK MIDDAY BRIEFING: Centrica Warns, Barclays Restructures
LONDON (Alliance News) - British gas parent Centrica has issued a profit warning Thursday, blaming the extreme winter weather in the US but mild conditions in the UK, as well as the intense pressure that's been put on energy providers in the UK in recent months by politicians
Read more8 May 2014 12:23
UK WINNERS & LOSERS: Standard Chartered, Barclays Lead FTSE 100 Risers
LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices midday Thursday.
-------
FTSE 100 - WINNERS
-------
Barclays, up 4.9%. Barclays has detailed plans to shrink its investment bank with a new round